Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111


Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Worm SW, De Wit S, Weber R, Sabin CA, Reiss P, El-Sadr W, Monforte AD, Kirk O, Fontas E, Dabis F, Law MG, Lundgren JD, Friis-Møller N.

Circulation. 2009 Feb 17;119(6):805-11. doi: 10.1161/CIRCULATIONAHA.108.790857. Epub 2009 Feb 2.


Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyand M, Reiss P, El-Sadr W, Monforte AD, Friis-Møller N, Lundgren JD, Law MG; D:A:D Study Group.

J Int AIDS Soc. 2012 Oct 10;15(2):17426. doi: 10.7448/IAS.15.2.17426.


Ten-year predicted coronary heart disease risk in HIV-infected men and women.

Kaplan RC, Kingsley LA, Sharrett AR, Li X, Lazar J, Tien PC, Mack WJ, Cohen MH, Jacobson L, Gange SJ.

Clin Infect Dis. 2007 Oct 15;45(8):1074-81. Epub 2007 Sep 12.


Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations.

Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin CA, El-Sadr W, d'Arminio Monforte A, Phillips AN, De Wit S, Kirk O, Dabis F, Pradier C, Lundgren JD, Law MG; D:A:D study group.

HIV Med. 2014 Nov;15(10):595-603. doi: 10.1111/hiv.12162. Epub 2014 May 19.


Coronary heart disease in HIV-infected individuals.

Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S.

J Acquir Immune Defic Syndr. 2003 Aug 1;33(4):506-12.


New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population.

Hadaegh F, Fahimfar N, Khalili D, Sheikholeslami F, Azizi F.

Cardiovasc Diabetol. 2010 Dec 4;9:84. doi: 10.1186/1475-2840-9-84.


Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.

Worm SW, Sabin CA, Reiss P, El-Sadr W, Monforte Ad, Pradier C, Thiebaut R, Law M, Rickenbach M, De Wit S, Lundgren JD, Friis-Møller N.

Diabetes Care. 2009 Mar;32(3):474-80. doi: 10.2337/dc08-1394. Epub 2008 Dec 3.


Comparative trends in the incidence of hospitalized myocardial infarction and coronary heart disease in adults with and without diabetes mellitus in Western Australia from 1998 to 2010.

Nedkoff L, Knuiman M, Hung J, Briffa TG.

Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):708-17. doi: 10.1161/CIRCOUTCOMES.114.000952. Epub 2014 Aug 26.


Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study.

Rasmussen LD, Mathiesen ER, Kronborg G, Pedersen C, Gerstoft J, Obel N.

PLoS One. 2012;7(9):e44575. doi: 10.1371/journal.pone.0044575. Epub 2012 Sep 12.


Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Klein D, Hurley LB, Quesenberry CP Jr, Sidney S.

J Acquir Immune Defic Syndr. 2002 Aug 15;30(5):471-7.


Prevalence of multiple cardiac risk factors in US adults with diabetes.

McCollum M, Ellis SL, Morrato EH, Sullivan PW.

Curr Med Res Opin. 2006 Jun;22(6):1031-4.


Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862.


Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

De Wit S, Sabin CA, Weber R, Worm SW, Reiss P, Cazanave C, El-Sadr W, Monforte Ad, Fontas E, Law MG, Friis-Møller N, Phillips A; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Diabetes Care. 2008 Jun;31(6):1224-9. doi: 10.2337/dc07-2013. Epub 2008 Feb 11.


Adverse events during treatment of drug-resistant tuberculosis: a comparison between patients with or without human immunodeficiency virus co-infection.

Sagwa E, Ruswa N, Musasa JP, Mantel-Teeuwisse AK.

Drug Saf. 2013 Nov;36(11):1087-96. doi: 10.1007/s40264-013-0091-1.


Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).

Petoumenos K, Worm S, Reiss P, de Wit S, d'Arminio Monforte A, Sabin C, Friis-Møller N, Weber R, Mercie P, Pradier C, El-Sadr W, Kirk O, Lundgren J, Law M; D:A:D Study Group.

HIV Med. 2011 Aug;12(7):412-21. doi: 10.1111/j.1468-1293.2010.00901.x. Epub 2011 Jan 20.


Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease.

Alexander CM, Landsman PB, Teutsch SM.

Am J Cardiol. 2000 Nov 1;86(9):897-902.


The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C.

Freiberg MS, Chang CC, Skanderson M, McGinnis K, Kuller LH, Kraemer KL, Rimland D, Goetz MB, Butt AA, Rodriguez Barradas MC, Gibert C, Leaf D, Brown ST, Samet J, Kazis L, Bryant K, Justice AC; Veterans Aging Cohort Study.

Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):425-32. doi: 10.1161/CIRCOUTCOMES.110.957415. Epub 2011 Jun 28.


A coronary heart disease risk model for predicting the effect of potent antiretroviral therapy in HIV-1 infected men.

May M, Sterne JA, Shipley M, Brunner E, d'Agostino R, Whincup P, Ben-Shlomo Y, Carr A, Ledergerber B, Lundgren JD, Phillips AN, Massaro J, Egger M.

Int J Epidemiol. 2007 Dec;36(6):1309-18. Epub 2007 Jul 25.


Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.

Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, Monforte AD, Friis-Møller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J.

J Infect Dis. 2010 Feb 1;201(3):318-30. doi: 10.1086/649897.


Prediction of first events of coronary heart disease and stroke with consideration of adiposity.

Wilson PW, Bozeman SR, Burton TM, Hoaglin DC, Ben-Joseph R, Pashos CL.

Circulation. 2008 Jul 8;118(2):124-30. doi: 10.1161/CIRCULATIONAHA.108.772962.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk